Abstract
We have previously described the design and development of CI-988, a peptoid analogue of CCK-4 with excellent binding affinity and selectivity for the CCK-B receptor. Due to its anxiolytic profile in animal models of anxiety, this compound was developed as a clinical candidate. However, during its development, it was determined that CI-988 had low bioavailability in both rodent and nonrodent species. In the clinic, it was further established that CI-988 had poor bioavailability. Thus, there was a need to identify an analogue with an improved pharmacokinetic (PK) profile. The poor bioavailability was attributed to poor absorption and efficient hepatic extraction. We envisaged that reducing the molecular weight of the parent compound (5, MW = 614) would lead to better absorption. Thus, we synthesized a series of analogues in which the key alpha-methyltryptophan and adamantyloxycarbonyl moieties, required for receptor binding, were kept intact and the C-terminus was extensively modified. This SAR study led to the identification of tricyclo[3.3.1.1(3,7)]dec-2-yl [1S-[1 alpha(S*)2 beta]-[2-[(2-hydroxycyclohexyl)amino]-1-(1H-indol-3- ylmethyl)-1-methyl-2-oxoethyl]carbamate (CI-1015, 31) with binding affinities of 3.0 and 2900 nM for ...Continue Reading
References
Sep 1, 1991·British Journal of Pharmacology·L SinghG N Woodruff
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J HughesG N Woodruff
Jan 1, 1991·Journal of Medicinal Chemistry·D GibsonJ Katzhendler
Dec 1, 1990·Pharmaceutical Research·H W FrijlinkC F Lerk
Dec 1, 1988·Journal of Medicinal Chemistry·B E EvansR S Chang
Jul 1, 1987·Journal of Medicinal Chemistry·B E EvansD F Veber
Mar 5, 1993·Journal of Medicinal Chemistry·P R BodenG N Woodruff
Mar 18, 1994·Journal of Medicinal Chemistry·G A ShowellG R Marshall
Dec 1, 1995·Biological Psychiatry·J BradwejnA Sedman
May 1, 1996·Journal of Pharmaceutical and Biomedical Analysis·J P HintonD S Wright
Citations
May 20, 1999·Psychiatry Research·A W GoddardL H Price
Jun 15, 1999·Progress in Neurobiology·F Noble, B P Roques
Feb 26, 2013·Chemical Reviews·Lukas WankaPeter R Schreiner
Jul 27, 1999·Current Opinion in Chemical Biology·R M Freidinger
Nov 5, 2014·Biopolymers·Marco Crisma, Claudio Toniolo
Oct 10, 2001·Biopolymers·A EscherichL Moroder
Sep 6, 2002·Journal of Peptide Science : an Official Publication of the European Peptide Society·Dirk WeberHorst Kessler
Jun 6, 2003·Medicinal Research Reviews·Rosario Herranz
Sep 1, 2006·Cancer Chemotherapy and Pharmacology·Alan P BrownMichael J Graziano
Mar 25, 2019·Journal of Women & Aging·Liam FosterDinali Wijeratne
Apr 4, 2015·Public Understanding of Science·Annamaria Lusardi
Oct 3, 2000·The Journal of Biological Chemistry·K TokitaR T Jensen
Aug 14, 2020·Chembiochem : a European Journal of Chemical Biology·Jian-Dong ZhangHong-Hong Chang
Dec 20, 2011·Biopolymers·J Aaron CrapsterHelen E Blackwell
Mar 29, 2020·Biotechnology Letters·Ya-Wen ChangJian-He Xu
Mar 7, 2021·Chirality·Pankaj GuptaNaveen Anand
Nov 17, 2001·Chemical Reviews·F Fülöp
Oct 6, 2000·Journal of Medicinal Chemistry·M Martín-MartínezR González-Muñiz
May 2, 2003·Journal of Medicinal Chemistry·Dirk WeberHorst Kessler
Aug 23, 2003·European Journal of Medicinal Chemistry·Bruno Bellier, Christiane Garbay
May 23, 2020·Drug Discovery Today·Doroteja NovakPetra Kolenc Peitl
Apr 17, 1998·Journal of Medicinal Chemistry·J K PadiaL Webdale
Nov 29, 2005·Journal of Chemical Information and Modeling·Madhu Chopra, Anil K Mishra
Dec 22, 2006·Journal of Medicinal Chemistry·Stephen A Hitchcock, Lewis D Pennington
Nov 24, 2005·Journal of Medicinal Chemistry·Mercedes Martín-MartínezRosario González-Muñiz